Serum levels of insulin-like growth factor I are reduced in patients with Type 1 (insulin-dependent) diabetes mellitus. To evaluate the role of the hepatic growth hormone receptor in the decreased serum concentrations of insulinlike growth factor I, serum levels of the high affinity growth hormone-b
Regulation of insulin-like growth factor binding protein-1 (IGFBP-1) in insulin-dependent diabetes mellitus
β Scribed by J. Fowelin; S. Attvall; H. Schenck; U. Smith; I. Lager; K. Hall
- Publisher
- Springer
- Year
- 1994
- Tongue
- English
- Weight
- 431 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0940-5429
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Multiple factors contribute to the growth retardation which is a characteristic feature of uncontrolled diabetes. In this report we have examined the effects of streptozotocin-induced (STZ) diabetes on expression of insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-
## Abstract Insulinβlike growth factor (IGF)βbinding proteinβ1 (IGFBPβ1), the main secretory protein of decidua that binds to IGFs and has been shown to inhibit or stimulate IGFs' bioactivities. Polymerization, one of the posttranslational modifications of IGFBPβ1, has been shown to lead to loss of
Previous studies have suggested that nerve regeneration may be defective in patients with diabetic polyneuropathy. Since insulin-like growth factor I (IGF-I) has been shown to stimulate nerve regeneration, and IGF binding protein-1 is acutely regulated by plasma insulin we have investigated the rela
We have previously shown that the insulin-like growth factors (IGFs) stimulate both proliferation and differentiation of skeletal muscle cells in culture, and that these actions in L6A1 muscle cells may be modulated by three secreted IGF binding proteins (IGFBPs), IGFBP-4, -5, and -6. Since we found